News | News By Subject | News by Disease News By Date | Search News

Vaccine News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Biotech Unicorn Moderna's Vaccine Performs Well in First Human Trial     5/1/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine     4/18/2017
Google (GOOG) Backs Another Biotech Startup: This One Wants to Develop a 'Biotech Superglue' to Create New Vaccines     4/3/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial     2/22/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
FDA Slaps Partial Hold on Bay Area Firm Aduro Biotech (ADRO)'s Cancer Vaccine Trial     10/25/2016
Anthrax Vaccine Maker Emergent BioSolutions (EBS) Lays Off 91 in Michigan     10/6/2016
Novavax (NVAX) Stayin' Alive After Shares Crater on Flunked Phase III     9/19/2016
Vaxart Challenges Takeda (TKPYY) with Oral Norovirus Vaccine     8/8/2016
Altimmune Receives BARDA Contract Of Up To $120.2 Million To Fund Clinical Development Of First-In-Class Anthrax Vaccine Candidate Nasoshield     8/2/2016
FDA Clears Expanded Approval of Pfizer (PFE)'s Best-Selling Pneumonia Vaccine     7/13/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines     3/25/2016
Valneva Snags $42 Million IXIARO Supply Contract with US Government     3/16/2016
Celldex (CLDX) Stock Chokes as Brain Cancer Trial Halted     3/8/2016

News from Around the Web
What's Happening With Sanofi (SNY)'s Controversial Zika Deal With The Army     5/26/2017
Yet Another Measles Outbreak Traces Directly To Antivaccine Autism Panic     5/8/2017
Flugen, Inc. Raises $2M More, Provides Update on Phase I Trial     4/12/2017
Breaking The Cold Chain: New Vaccine Doesn't Need Refrigeration     3/23/2017
Meet VBI Vaccines, The Biotech Up 100% In 2017     3/8/2017
Above The Rise Of Merck & Co. (MRK)’s Gardasil Vaccine, A Specter Is Looming     2/3/2017
Bill Gates Is Teaming Up With World Leaders To Stop The Next Deadly Pandemic     1/20/2017
5 Facts Donald Trump Needs To Know About Vaccines     1/11/2017
Philippine FDA Orders Sanofi (SNY) To Take Down Dengue Vaccine Ads     1/5/2017
An Experimental Zika Vaccine Is Being Tested In Humans — And Bill Gates Is Picking Up The Tab     12/5/2016
Gutsy Anti-Vaccine Activists Spot An Ally In The Oval Office     11/30/2016
Flu Vaccine During Pregnancy Not Linked To Autism, Published In JAMA     11/29/2016
Couple Accuses Merck & Co. (MRK) Of Failing To Disclose Zostavax Vaccine Side Effects     11/18/2016
Here Are 3 Ways To Play The Growing Market For Vaccines Right Now     11/11/2016
The $5.8 Billion Hidden Cost Of The Flu On The U.S. Economy     10/31/2016

Press Releases
Inovio Pharma (INO) HIV Vaccine Elicits Nearly 100% Immune Response Rates In A Clinical Study     5/24/2017
United Neuroscience Reports Positive Phase I Results For Active Vaccine UB-311 In Alzheimer’s Disease     5/23/2017
Cincinnati Children's Hospital Medical Center Release: Year-Round Flu Vaccinations Promote Healthier Infants In Subtropics     5/16/2017
Meissa Vaccines Announces Award Of NIH SBIR Grant To Support Development Of Multivalent Human Rhinovirus Vaccine Candidate     5/10/2017
TechnoVax Inc. Release: Promising Zika Virus Vaccine Candidate     5/9/2017
Soligenix (SNGX) Receives Japanese Patent For ThermoVax Vaccine Heat Stabilization Platform Technology     5/9/2017
Hookipa Biotech Presents Positive Data From Phase I First-In-Human Trial Of Vaccine Against Cytomegalovirus     5/4/2017
The Emmes Corporation Expands Zika Vaccine Research     5/3/2017
SRI International Awarded $4.7 Million In Agreements To Manufacture And Test Vaccine Against Venezuelan Equine Encephalitis     4/28/2017
Moderna Announces Positive Interim Phase I Clinical Data Demonstrating First mRNA Vaccine Candidate, mRNA-1440, Induces High Levels Of Immunogenicity     4/27/2017
Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio     4/24/2017
CanSino Biologics Raises $65 Million For Vaccine Development     4/18/2017
Immunovaccine Announces Positive Year-Long Immunogenicity Data From Phase I Clinical Trial For Respiratory Syncytial Virus Vaccine Candidate     4/12/2017
Inovio Pharma (INO) Ebola Vaccine Demonstrates Robust Immune Responses With Favorable Safety Profile In Expanded Clinical Trial     4/11/2017
Inovio Pharma (INO) Ebola Vaccine Demonstrates Robust Immune Responses With Favorable Safety Profile In Expanded Clinical Trial     4/11/2017